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This model testimony is based off of specific testimony
Meredith Jacob has submitted to various state
legislatures advocating the passage of "Data-Mining"
legislation.
Dear Chairman and Members of the Committee:
I am pleased to submit these comments on the practice
of prescriber profiling and the sale of physicianspecific prescription data. My comments provide an
overview of the practice of prescription data-mining, a
review of legislation passed in other states to regulate
it., and an analysis of the recent decision of the United
State Court of Appeals for the First Circuit upholding
the New lampshire data-mining restriction.
My name is Meredith Jacob and I am a pharmaceutical
policy fellow at the Program on Information Justice and
Intellectual Property (IPIJIP) at American IUniversity
Washington College of Iavs. I am here on behalf of
the Prescription Project of Community Catalyst,
as well as the National ILegislative Association on
Prescription Drug Prices. PhIP's associate director,
Sean Flynn, serves as counsel to the Prescription
Project of Community Catalyst and to the National
Legislative Association on Prescription Drug Prices.
These organizations strongly support the passage
of legislation to regulate "data-mining" by the
pharmaceutical industry.

IL.The UJse and.Abuse of
P res c rip tIo n D a ta -Min i in",g
The practice of prescription data-mining dates back to
the earlx 199 0s, when prescription records went digital
and pharmacy benefit managers (PBMs) became
widespread. These organizations sought to digitize
prescription records so claims could be expedited
through an online process, creating the possibility of
quickly transferring the records to others. Over the last
decade or so. a multi-billion dollar "health information"
industry has emerged to buy prescription records from

pharmacies, PIBMs and other intermediaries to compile
massive databases on the prescribing habits of nearly
every physician and other licensed prescriber in the
country.
The records are then used by pharmaceutical companies
to promote incredibly sophisticated marketing efforts
to doctors. Pharmaceutical companies use the records
to determine which doctors are more susceptible to
various kinds of sales messages, which doctors are
more prone to using new drugs, whether a doctor is
"brand loyal" to a certain manufacturer, and which
doctors should be rewarded for their prescribing
practices with high paying consultancies. advisory
board positions, and scholarships to "educational"
seminars. Data-mining has radically increased the
influence of marketers by allowing them to specifically
observe and reward the most profitable prescribing
practices while tailoring switching messages to those
not using desired products.'
Access to prescribing data stoked a massive increase
in spending and sales force size for individualized
marketing. According to the First Circuit's examination of the record in the New Hampshire case, pharmaceutical companies spend at least $4 billion annually
on detailing to doctors.
In the decade after IMS Health Inc., a large Health
Infonnation Organization, unveiled its flagship prescriber tracking program in 1993, spending on detailing increased by nearly 300 percent,3 doubling the
number of pharmaceutical sales representatives to
over 100,000. TIhere is now one pharmaceutical sales
representative for every ftour to five olflice-based physicians in the nation. Because low prescribers often do

not receive sales attention, it has been estimated that
the eflective ratio of sales representatives to targeted
doctors is closer to one for every 2.5 doctors. The average primary care physician in 2004 interacted with a
staggering 28 sales representatives each week.
States are now acting to regulate this use of prescription
data tor sexveral core reasons.
First, prescriptions are part of medical records that
document priv ate decisions made in the context
of the doctor patient relationship. Permitting
commercial use of these records improperly injects
maiketing influence into the exam ioom.

. Second, there is a large amount of data displaying
that drug marketers in the United States are exerting
undue influence over the prescribing practices,
which is contributing to irrational prescribing
practices that harm public health and unnecessarily
raise the cost of health care.
Third, access to this data is corrupting the medical
profession by allowing companies to use advisory
board appointments, consultancies and gifts as
direct payment for observed prescribing practices.
Finally, doctors themselves are pushing for
this legislation in many states because access
to individualized data is promoting the use of
harassing and vexatious sales practices in which
sales representatives attempt to hold doctors
"accountable" for gifts and promises as they race
toward the massive bonuses companies provide
to reps based on their ability to shift prescribing
practices.
All of these purposes provide ample justification for
state regulation in this area, regardless of any "free
speech" arguments raised by the industry.

_II.
State Regulation of
'ata -Min
iin g:_11First Circuit
U(pholds the New Hampshire
Prescription Privacy Akct
New Hampshire., in passing its Prescription Confidentiality Act, 6 was the first state in the nation to
ban the trade in prescriber-identilied prescription data
for marketing purposes. Following the passage of the
New Hampshire Act, Vermont and Maine passed
laws that give physicians the right to opt-in or opt-out
of sharing their prescription records.
T-he first-in-the-nation prescription confidentia lity
law in New Hampshire was recently upheld under a
constitutional challenge bx the First Circuit Court of
Appeals. All three judges on the First Circuit agreed
that the lawx's core purpose of cuibing irrational
prcscribing of higher priced drugs duc to undue
influence of marketers wxas sufficient in itself to justify
any encroachment on the comnpanies' "comercial
speech" rights. Two judges held that thc laxs did not
actually regulate any speech because prescription
records sold as a commodity on commercial markets
are subject to traditional economic regulation free
ot any First Amendment inquiry. IThe third judge
thought that the lass did affect the commercial speech
of (letailers, by prohibiting them from informing their
messages with the records, but held nevertheless that
the law was adequatelx

justified.9

The first area of inquiry for the First Circuit was
whether the use of prescriber-identifiable data should
be classified as speech. Here, the court found that the
use of data prohibited by the New Hampshire Act
constituted conduct, not speech. The Court reviewed
other cases where language-related activities were
regulated as conduct, rather than speech, and found
that in the case at hand there was "scant societal value"
to any informational component of the marketing uses
of prescription data.
The Court noted that, in this situation. information had
become a commodity, and could be regulated as such.
The sale of prescription data did nothing to increase
the free flow of information to doctors or patients, or
to inform their decision-making in the marketplace.
Finally, the Court reviewed precedent establishing that
state actions that made speech unprofitable did not
restrict speech, and observed that no provision of the
New Hampshire Act foreclosed publication or open
discussion of prescriber data.

IX Crainiikg aFu

R cr

Although the only circuit court to address the issue
unanimously held that states have every right to ban
the sale of prescription records to serve public health
concerns, the litigation in these cases indicates that
legislatures must carefllly justify their actions to
survive court scrutiny. It any thing, the risks oflitigation
for the next state to act in this area have increased. The
pharmaceutical industry is now looking for a circuit
split so it can take this issue to the Supreme Court.
The most important thing this Commxittee can doother than carefully crafting legislation-is to create
a full and persuasive record displaying the reasons for
its action in this area. While data-mining legislation
should not be subject to First Amendment scrutiny,
the Committee should assume that a court may
differ on this opinion and that the law will have to
meet what courts term "intermediate scrutiny." This
means that the la must diiectly sexe a "substantial
goxernmcnt intercst" and be reasonably tailored
to that interest. Therc is a xxealth of documentary
ev idence and expcrt tcstimony that can be brought to
bear on these issues.

States haxve a paramount interest in comnbating undue
influence of pharmaceutical marketers oxver prescribing
decisions. Nearly all direct-to-prescriber marketing
is one-sided because only the most expensive and
profitable medicines, that is branded blockbuster

drugs, are marketed through in-person detailing."

Access to prescribing data aggravates the negative
impact of this one-sided information market by
permitting branded medicine marketers to observe
and reward favored prescribing behavior." The most
favored prescribers can receive hundreds of thousands
of dollars in payments from drug companies for
speaking engagements, research, and sitting on various
advisory boards.i
Numerous studies and investigations have documented
a significant, measurable, and increasing influence of
direct-to-physician marketing by convincing doctors
to adopt prescribing practices that are contrary
to clinical guidelines and the weight of objective
scientific evidence.1 An exhaustive data synthesis
from over 500 published studies has found conclusive
evidence that pharmaceutical detailing guided by
access to prescribing data "impact[s] the prescribing
practices of residents and physicians in terms of
prescribing cost, non-rational prescribing, awareness,
preference and rapid prescribing of new drugs, and
decreased prescribing of generic drugs." 14 The same
study concluded that meetings with pharmaceutical
representatives had a direct relationship to physician
requests to add drugs to a formulary that had "little
or no therapeutic advantage over existing forniulary
drugs."1

DatMnig ueled Marketi,,ng Icreases
Wihout Beefit toPatients
Cost
T-he aggregate financial costs to society of undue
influence by pharmaceutical marketers are enormous.
Many examples exist exhibiting the successes of the
super-charged pharmaceutical marketing system at
shifting massive amounts of prescriptions toward
newer, more expensive drugs that do not benefit
patients. In 2007, while generic medicines accounted
for 65% of prescriptions filled, generics were only
responsible for approximately 20% of prescription
costs. 1 Reducing the non-medically appropriate
oseruse of bianded pharmaceuticals is essential to
controlling health caie costs. Another study found
that approximately 40%~ of Pennsylvsania Medicare
patients on antihxypertcnsixve

therapy we rc hcing
preseiibed medications at odds wsith clinieal guidelines, at a eost of $11.6 million per year in that state
alonle. Extrapolated to national lexvels, that same study
found that marketing-drisven non-rational preseribing
costs the nation $1.2 billion for that class of drugs
alone."

Increased cost of medications has a direct effect on
patient health. In 2007, a review of medical literature
found that up to 32% of seniors took less medicine
than prescribed in an effort to reduce costs." When
data-mining drives the prescription of more expensive
alternatives, patients are needlessly forced to make
purchasing decisions that can endanger their health.

IData-Minin,,g Accelerates
Unsupportd, O1
verly-Broa d Ado\pion
ouf th-.,e Newest Druigs
One of the clear effects of data-mining in marketing is
that it demonstrably shifts prescribing patterns toward
newer drugs. But now there is a growing awareness
that the rapid uptake of new drugs may threaten patient
health in many areas where older therapies should
remain the first line drugs of choice.Q Newer drugs
often have unknown side effects and less developed
safety profiles, in comparison to drugs that have been
on the market for significant periods of time.
T-his efflect can be seen in the incredible marketing
push and resultant prescription surge for Vioxx,.
Celebrex, and other COX 2 inhibitors, despite the lack
of any conclusive medical evidence that they were
more effective than older pain medications, or that
the reduction in gastric side effects were significant
for most patients. In the case of Vioxx, aggressive
marketing using prescriber data helped facilitate
the widespread adoption of a drug that was far more
dangerous to patient health than existing alternatives
or than the company's marketing messages admitted.

Reglatonof Dt-iigMaf-intains
Standads inthe Medical Profession
Many physician organizations advocate an end to
prescriber-identified data trading for marketing
purposes because the practice threatens the ethical
standards of the profiession and jeopardizes physicians'
relations with patients by permitting phaimaceutical
companies to give pecuniary rewards to medical
professionals Wased on their prescriing habits.
bans and reporting are one good policy tool.
But it is difficult and perhaps impossible to ban all
(Gilt

payments to doctors by phaimaceutical companies,
because some legitimate ioles exist for ph>ysicians in
clinical trials and othei consulting ioles. By banning
sale of prescriber data, swe can eliminate payments to
ph>ysicians based on the drugs they prescribe, iather
than wxork they do.
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